中文版
English
Jetide Health
Wuhan Jetide Biotech Co., Ltd. is a prominent enterprise in the field of small molecule peptides, with three wholly-owned subsidiaries: Hubei Huntide Biotech Co., Ltd., Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd., and Wuhan Jason Biotech Co., Ltd. Since its establishment in September 2012 in Wuhan, Hubei Province, the company has been dedicated to the R&D, production, and sales of small molecule peptides. Leveraging strong technical expertise and market insight, it has gradually built a solid reputation in the industry.
The company possesses 200 mu (approximately 13.3 hectares) of chemical industry land and 20,000 square meters of self-built production facilities, providing ample space for large-scale manufacturing and R&D. Currently, it operates four industrialized production lines with an annual capacity of 1,000 metric tons of small molecule peptides, ensuring strong production support to meet market demand.
In terms of R&D capabilities, Wuhan Jetide has a professional team of over 30 members, each with more than 10 years of experience in the development of small molecule peptide synthesis. The team has extensive expertise in synthesis, purification, and analytical technologies related to small molecule peptides, enabling them to undertake custom synthesis and industrial-scale amplification of various small molecule peptides, thereby providing tailored solutions for clients.
Furthermore, the company fully implements GMP management, strictly adhering to GMP standards throughout all processes—from raw material procurement, production control, and quality testing to sales and after-sales services. This not only ensures product quality and safety but also meets various audit requirements of domestic and international clients, earning the company widespread trust and cooperation opportunities.
Looking ahead, Wuhan Jetide will continue to deepen its expertise in the field of small molecule peptides, continuously enhance its technological innovation capabilities，expand production scale, and improve product quality and production efficiency. Meanwhile, the company will actively explore both domestic and international markets, seek more partnerships and business opportunities, and contribute to the advancement of the biotechnology industry.
2018/06/13
Jetide Mobile station